Quest Diagnostics Incorporated (DGX) Income Statement
DGX 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsDGX revenue and net income
Where DGX's revenue goes
2025Each bar shows an amount and its share of revenue. DGX kept 9.0% of revenue as net income.
DGX profit margins
DGX growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +11.8% | +3.7% | +3.2% | +3.9% |
| Gross profit | +8.6% | +0.9% | −0.6% | +2.2% |
| Operating income | +19.1% | +3.9% | −4.0% | +1.4% |
| Net income | +13.9% | +1.6% | −7.1% | +3.4% |
| EPS (diluted) | +10.4% | −0.2% | −2.4% | +7.5% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DGX quarterly EPS vs estimates
Quest Diagnostics beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 22, 2026 (estimate $2.85).
DGX income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.71B | $7.51B |
| Cost of revenue | $7.51B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B |
| Gross profit | $3.52B | $3.24B | $3.05B | $3.43B | $4.21B | $3.63B | $2.69B | $2.60B | $2.99B | $2.90B |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $1.92B | $1.77B | $1.80B | $1.82B | $1.73B | $1.55B | $1.46B | $1.42B | $1.75B | $1.68B |
| Total operating expenses | $1.92B | $1.90B | $1.64B | $2.00B | $1.83B | $1.66B | $1.46B | $1.50B | $1.82B | $1.74B |
| Operating income | $1.60B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B |
| Interest income | $264.0M | $25.0M | $9.0M | $138.0M | $151.0M | $163.0M | $5.0M | $2.0M | $2.0M | $1.0M |
| Interest expense | $277.0M | $226.0M | $152.0M | $148.0M | $152.0M | $166.0M | $180.0M | $169.0M | $153.0M | $143.0M |
| Income before taxes | $1.36B | $1.19B | $1.13B | $1.28B | $2.68B | $1.96B | $1.13B | $926.0M | $1.03B | $1.09B |
| Income taxes | $314.0M | $273.0M | −$248.0M | $264.0M | $597.0M | $460.0M | $247.0M | $182.0M | $241.0M | $429.0M |
| Net income | $992.0M | $871.0M | $854.0M | $946.0M | $2.00B | $1.43B | $858.0M | $736.0M | $772.0M | $645.0M |
| EBITDA | $2.19B | $1.89B | $1.26B | $1.82B | $3.16B | $2.41B | $1.58B | $1.40B | $1.45B | $1.48B |
| EPS (diluted) | $9.85 | $8.92 | $8.71 | $9.92 | $14.23 | $11.15 | $6.56 | $6.31 | $5.67 | $5.14 |
| Gross margin | 31.9% | 32.9% | 33.0% | 34.7% | 39.0% | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% |
| Operating margin | 14.5% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% |
| Net margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B |
| Cost of revenue | $2.02B | $1.95B | $1.89B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B |
| Gross profit | $1.03B | $942.0M | $914.0M | $949.0M | $943.0M | $863.0M | $858.0M | $811.0M | $804.0M | $771.0M | $740.0M | $754.0M |
| Sales, general & admin | $529.0M | $504.0M | $486.0M | $501.0M | $486.0M | $476.0M | $466.0M | $448.0M | $416.0M | $440.0M | $407.0M | $376.0M |
| Total operating expenses | $568.0M | $543.0M | $523.0M | $563.0M | $505.0M | $517.0M | $497.0M | $481.0M | $449.0M | $471.0M | $473.0M | $412.0M |
| Operating income | $459.0M | $399.0M | $391.0M | $386.0M | $438.0M | $346.0M | $361.0M | $330.0M | $355.0M | $300.0M | $267.0M | $342.0M |
| Interest income | $5.0M | $2.0M | $64.0M | $3.0M | $2.0M | $5.0M | $7.0M | $9.0M | $3.0M | $6.0M | $6.0M | $40.0M |
| Interest expense | $63.0M | $63.0M | $67.0M | $69.0M | $69.0M | $72.0M | $72.0M | $58.0M | $47.0M | $49.0M | $46.0M | $41.0M |
| Income before taxes | $412.0M | $334.0M | $337.0M | $336.0M | $393.0M | $294.0M | $304.0M | $302.0M | $314.0M | $274.0M | $245.0M | $305.0M |
| Income taxes | $88.0M | $74.0M | $81.0M | $77.0M | $97.0M | $59.0M | $68.0M | $65.0M | $74.0M | $66.0M | $40.0M | $68.0M |
| Net income | $320.0M | $252.0M | $245.0M | $245.0M | $282.0M | $220.0M | $222.0M | $226.0M | $229.0M | $194.0M | $192.0M | $225.0M |
| EBITDA | $589.0M | $544.0M | $546.0M | $547.0M | $596.0M | $488.0M | $507.0M | $479.0M | $478.0M | $431.0M | $392.0M | $451.0M |
| EPS (diluted) | $3.12 | $2.50 | $2.42 | $2.60 | $2.62 | $2.21 | $2.23 | $2.30 | $2.35 | $2.04 | $2.15 | $2.22 |
| Gross margin | 33.7% | 32.5% | 32.6% | 33.7% | 34.2% | 32.5% | 32.7% | 32.6% | 33.5% | 32.6% | 32.3% | 32.9% |
| Operating margin | 15.1% | 13.8% | 13.9% | 13.7% | 15.9% | 13.0% | 13.8% | 13.3% | 14.8% | 12.7% | 11.7% | 14.9% |
| Net margin | 10.5% | 8.7% | 8.7% | 8.7% | 10.2% | 8.3% | 8.5% | 9.1% | 9.6% | 8.2% | 8.4% | 9.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DGX's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DGX financial results
In fiscal year 2025 (ended December 31, 2025), Quest Diagnostics reported revenue of $11.0 billion, up 11.8% from the year before. It had net income of $992.0 million (up 13.9%), a net profit margin of 9.0%. Diluted earnings per share came to $9.85. Over five years revenue grew at an average rate of 3.2% a year.
See the DGX stock overview for the latest quote and news, or the DGX chart for price history and technical indicators.
DGX income statement FAQ
What is Quest Diagnostics's annual revenue?
Quest Diagnostics reported total revenue of $11.0 billion for fiscal year 2025, which ended on December 31, 2025. That was up 11.8% from $9.9 billion the previous year.
Is Quest Diagnostics profitable?
Yes. Quest Diagnostics reported net income of $992.0 million in fiscal 2025, a net profit margin of 9.0%; its operating margin was 14.5%.
What is Quest Diagnostics's gross margin?
Quest Diagnostics's gross margin was 31.9% in fiscal 2025: for every $100 of revenue, Quest Diagnostics kept $32 after the direct cost of its products and services.
How fast is Quest Diagnostics growing?
Revenue grew 3.2% a year on average over the last five fiscal years, from $9.4 billion to $11.0 billion.
What are Quest Diagnostics's earnings per share?
Quest Diagnostics earned $9.85 per diluted share in fiscal 2025, compared with $8.92 a year earlier.
When will Quest Diagnostics report its next earnings?
Quest Diagnostics is expected to report results for the quarter ending September 30, 2026 on October 22, 2026 before the market opens.
When does Quest Diagnostics's fiscal year end?
Quest Diagnostics's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.